公司资料
Carisma Therapeutics, Inc. 股价、新闻与催化剂
- 股票代码:
- CARM
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.00 USD (0.00%)
收盘价
最后更新: 2026年11月5日
—
市值
股价为何变动
截至 2026年11月5日，CARM 股价变化不大，收于 $0.0005。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Carisma Therapeutics is a cell-therapy company focused on engineered macrophages and cancer immunotherapy. Its story centers on using a novel immune-cell approach to attack tumors.
所在地与行业分类
Carisma is headquartered in the United States and listed on NASDAQ. It sits in cell therapy and oncology biotechnology.
商业模式特征
The company depends on clinical validation, manufacturing feasibility, and capital support while it advances a narrow pipeline. Investors watch early data and platform differentiation.
生物医药行业定位
Carisma occupies a specialized macrophage-cell-therapy niche within biotech. It is catalyst-sensitive because the platform still needs to prove itself clinically.
未来催化剂
- Carisma’s catalysts are macrophage-engineering programs and any strategic or clinical update that clarifies the company’s next path. The company still needs stronger human proof.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。